Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Cash from Investing Activities: 2020-2025

Historic Cash from Investing Activities for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to $47.5 million.

  • Tango Therapeutics' Cash from Investing Activities rose 45.77% to $47.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.9 million, marking a year-over-year increase of 116.31%. This contributed to the annual value of $86.1 million for FY2024, which is 107.90% up from last year.
  • Latest data reveals that Tango Therapeutics reported Cash from Investing Activities of $47.5 million as of Q3 2025, which was up 182.97% from $16.8 million recorded in Q2 2025.
  • Tango Therapeutics' Cash from Investing Activities' 5-year high stood at $52.1 million during Q4 2024, with a 5-year trough of -$152.2 million in Q3 2021.
  • Over the past 3 years, Tango Therapeutics' median Cash from Investing Activities value was $31.6 million (recorded in 2023), while the average stood at $20.2 million.
  • In the last 5 years, Tango Therapeutics' Cash from Investing Activities surged by 635.74% in 2022 and then crashed by 472.10% in 2023.
  • Over the past 5 years, Tango Therapeutics' Cash from Investing Activities (Quarterly) stood at -$45.2 million in 2021, then skyrocketed by 72.12% to -$12.6 million in 2022, then spiked by 368.56% to $33.9 million in 2023, then soared by 53.79% to $52.1 million in 2024, then skyrocketed by 45.77% to $47.5 million in 2025.
  • Its Cash from Investing Activities was $47.5 million in Q3 2025, compared to $16.8 million in Q2 2025 and $30.6 million in Q1 2025.